menu
    • menu

    Company profile for Enveda Bioscience

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Enveda, we’re harnessing the complexity of the natural world to tackle today’s biggest healthcare challenges. With breakthrough advancements in machine learning, computational metabolomics, and knowledge graphs, we’re discovering the next generation of small molecules.Our technologies systematize discovery of first-in-class small molecules and novel targets for complex diseases. By probing novel chemical space and mec...
    At Enveda, we’re harnessing the complexity of the natural world to tackle today’s biggest healthcare challenges. With breakthrough advancements in machine learning, computational metabolomics, and knowledge graphs, we’re discovering the next generation of small molecules.Our technologies systematize discovery of first-in-class small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, we are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. At we are systematically translating molecules found in medicinal

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enveda BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    611 Gateway Blvd, Suite 120, South San Francisco, CA 94080
    Telephone
    Telephone
    +1-415-323-5252
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.envedabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/envedabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enveda Names Christopher K. Porter SVP, Clinical Operations
    Enveda Names Christopher K. Porter SVP, Clinical Operations

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/enveda-appoints-christopher-k-porter-mba-jd-as-senior-vice-president-clinical-operations

    PHARMIWEB
    15 Apr 2026
    Share Share
    Enveda's Oral Therapy Breakthrough in Atopic Dermatitis
    Enveda's Oral Therapy Breakthrough in Atopic Dermatitis

    06 Apr 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/biotech/envedas-experimental-oral-therapy-shows-breakthrough-results-in-atopic-dermatitis-trial-19574

    INDPHARMAPOST
    06 Apr 2026
    Share Share
    Enveda Launches Phase 1 Trial For First-In-Class Oral IBD Therapy
    Enveda Launches Phase 1 Trial For First-In-Class Oral IBD Therapy

    24 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/biotech/enveda-launches-phase-1-trial-for-first-in-class-oral-ibd-therapy-18670

    INDPHARMAPOST
    24 Dec 2025
    Share Share
    Enveda Secures FDA Clearance for Third IBD Asset in Clinic
    Enveda Secures FDA Clearance for Third IBD Asset in Clinic

    23 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251223284016/en/Enveda-Advances-Third-Asset-to-the-Clinic-With-US-FDA-IND-Clearance-and-Phase-1-Initiation-of-ENV-6946-a-First-in-Class-Oral-Multi-Biologic-in-a-Pill-for-Inflammatory-Bowel-Disease

    BUSINESSWIRE
    23 Dec 2025
    Share Share
    Enveda Announces ENV-308 IND Clearance, Appoints Sarwar as CSO
    Enveda Announces ENV-308 IND Clearance, Appoints Sarwar as CSO

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217651699/en/Enveda-Announces-US-FDA-IND-Clearance-and-First-Patient-Dosed-in-Phase-1-Trial-of-ENV-308-a-First-in-Class-Oral-Therapy-for-Obesity-Appoints-Nadeem-Sarwar-Ph.D.-MPharm-MPhil-to-Lead-Metabolic-Disease-Strategy

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    Enveda Launches Phase 2 of ENV-294 for Atopic Dermatitis, Asthma
    Enveda Launches Phase 2 of ENV-294 for Atopic Dermatitis, Asthma

    09 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209287981/en/Enveda-Initiates-Phase-2-Clinical-Trials-of-ENV-294-a-First-in-Class-Oral-Therapy-in-Atopic-Dermatitis-and-Asthma

    BUSINESSWIRE
    09 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search